These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4148682)

  • 1. [Rectal effect of salazopyrine in ulcerative colitis during a double-blind study].
    Schulz U; Hanke P; Seige K
    Wien Z Inn Med; 1973; 54(4):185-9. PubMed ID: 4148682
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sulfasalazine enema in acute left-sided ulcerative colitis (author's transl)].
    Frimberger E; Frühmorgen P; Kühner W; Ottenjann R
    MMW Munch Med Wochenschr; 1980 Sep; 122(36):1233-5. PubMed ID: 6108506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon.
    Frühmorgen P; Demling L
    Hepatogastroenterology; 1980 Dec; 27(6):473-6. PubMed ID: 6110627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [First experiences with serial biopsy of the rectal mucosa in inflammatory rectal-colonic diseases].
    Lisewski G; David H; Wilke E; Köhler W
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):155-6. PubMed ID: 4395945
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug therapy: Sulfasalazine.
    Goldman P; Peppercorn MA
    N Engl J Med; 1975 Jul; 293(1):20-3. PubMed ID: 236516
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effectiveness of packaged salicylazosulfapyridine (Azulfidine)-enema in proctitis, proto-sigmoiditis and left-sided colitis].
    Frühmorgen P
    Z Gastroenterol Verh; 1981 Jun; 19():36-7. PubMed ID: 6168132
    [No Abstract]   [Full Text] [Related]  

  • 7. [Salazosulfapyridine: old and new therapy concepts in inflammatory bowel diseases].
    Allgayer H; Kruis W
    Dtsch Med Wochenschr; 1985 Nov; 110(47):1827-9. PubMed ID: 2866083
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative analysis of systemic immunological parameters in ulcerative colitis and idiopathic proctitis: effects of sulfasalazine in vivo and in vitro.
    Rubinstein A; Das KM; Melamed J; Murphy RA
    Clin Exp Immunol; 1978 Aug; 33(2):217-24. PubMed ID: 31252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulcerative colitis, diverticulitis and the irritable colon syndrome.
    Flavell Matts SG
    Br J Clin Pract; 1972 Feb; 26(2):66-8. PubMed ID: 4401544
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of salazopyridazine in suppositories in chronic colitis].
    Nogaller AM; Averina TK
    Klin Med (Mosk); 1982 Apr; 60(4):43-7. PubMed ID: 6124655
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with the rectal azulfidine therapy].
    Hanke P; Schulz U
    Z Gesamte Inn Med; 1971 Nov; 26(21):Suppl:292-3. PubMed ID: 4402345
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical picture and therapy of nonspecific ulcerative proctitis (author's transl)].
    Schütze K; Hentschel E
    Wien Med Wochenschr; 1982 Feb; 132(4):91-3. PubMed ID: 6123196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.
    Cohen HD; Das KM
    J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S150-4. PubMed ID: 16885699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alveolitis and pulmonary fibrosis in chronic diverticulitis and ulcerative colitis].
    Büntzel J; Liebetrau G
    Pneumologie; 1994 Jan; 48(1):16-9. PubMed ID: 7908743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfasalazine-induced exacerbation of ulcerative colitis.
    Schwartz AG; Targan SR; Saxon A; Weinstein WM
    N Engl J Med; 1982 Feb; 306(7):409-12. PubMed ID: 6120459
    [No Abstract]   [Full Text] [Related]  

  • 16. [The prophylactic effect of salazosulfapyridine in ulcerative colitis after a period of one year without symptoms on long-term treatment. A double-blind investigation].
    Binder V; Bonnevie O; Folkenborg O; Anthonisen P; Wulff HR; Riis P
    Ugeskr Laeger; 1972 Oct; 134(40):2093-5. PubMed ID: 4405794
    [No Abstract]   [Full Text] [Related]  

  • 17. Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis.
    Gross V; Bar-Meir S; Lavy A; Mickisch O; Tulassay Z; Pronai L; Kupcinskas L; Kiudelis G; Pokrotnieks J; Kovács A; Faszczyk M; Razbadauskas A; Margus B; Stolte M; Müller R; Greinwald R;
    Aliment Pharmacol Ther; 2006 Jan; 23(2):303-12. PubMed ID: 16393311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal topical corticosteroid preparations.
    Drug Ther Bull; 1991 Aug; 29(17):66-8. PubMed ID: 1914871
    [No Abstract]   [Full Text] [Related]  

  • 19. Maintenance of remission in ulcerative colitis. Effect of an orally absorbed mast cell stabilizer.
    Davies PS; Rhodes J; Counsell B; Evans BK
    Am J Gastroenterol; 1980 Aug; 74(2):150-3. PubMed ID: 6108711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
    Andreoli A; Spinella S; Levenstein S; Prantera C
    Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.